baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Overview

Chart

News

NEXT BIOTECH/ QS0011095955

BIOTK

2018-10-19 12:00:00 AM	Chg. -	Open	High	Low	Previous Close
2,062.85XXP	-	2,125.20	2,062.85	2,062.85	2,122.28
2,062.85XXP	-	2,125.20	2,062.85	2,062.85	2,122.28

GlobeNewswire 03-11 PHAXIAM Therapeutics announces effectiveness of voluntary delisting of American Depositary Shares fr...

GlobeNewswire 02-20 PHAXIAM Therapeutics announces intention to voluntary delist American Depositary Shares from The Nas...

GlobeNewswire 01-18 PHAXIAM Therapeutics announces its cash position at the end of 2023 and its financial calendar for 2...

GlobeNewswire 2023-11-14 PHAXIAM Provides Business and Financial Update for the Third Quarter of 2023

GlobeNewswire 2023-10-24 PHAXIAM Therapeutics obtains authorizations to launch its phase 1 study in endocarditis infections c...

GlobeNewswire 2023-10-23 TP ICAP Midcap initiates coverage of PHAXIAM Therapeutics with a “Buy” recommendation

GlobeNewswire 2023-10-09 PHAXIAM Therapeutics announces high coverage performance of its two anti-Staphylococcus aureus phage...

GlobeNewswire 2023-10-04 PHAXIAM Receives Compliance Notice from Nasdaq

GlobeNewswire 2023-10-03 PHAXIAM Therapeutics and Vetophage Announce Strategic Research Collaboration

GlobeNewswire 2023-09-21 PHAXIAM Provides Business and Financial Update For the First Half of 2023

GlobeNewswire 2023-09-19 PHAXIAM Therapeutics extends its phage portfolio to Klebsiella pneumoniae, a new resistant and aggre...

GlobeNewswire 2023-09-18 PHAXIAM Therapeutics announces the completion of its reverse share split

GlobeNewswire 2023-09-05 PHAXIAM Therapeutics publishes its cash position and new financial calendar, and announces its parti...

GlobeNewswire 2022-03-28 ERYTECH to Participate in the Upcoming April Investor Conferences

GlobeNewswire 2022-03-11 ERYTECH Provides Business and Financial Update for the Fourth Quarter and Full Year 2021

GlobeNewswire 2022-02-08 ERYTECH Expands Patent Portfolio for the Treatment of Rare Metabolic Diseases

GlobeNewswire 2022-01-24 ERYTECH Announces Presentation of Results of Two Clinical Trials of Eryaspase in Pancreatic Cancer...

GlobeNewswire 2022-01-03 ERYTECH to Participate in the Upcoming January Virtual Investor Conferences

GlobeNewswire 2021-12-14 ERYTECH Announces $7.85 Million Registered Direct Offering

GlobeNewswire 2021-12-13 ERYTECH Announces Presentation of Results of Expanded Access Program in ALL at 2021 ASH Annual Meeti...

GlobeNewswire 2021-11-29 ERYTECH Secures US Patent Directed to Sequential Use of Methioninase & Asparaginase against Solid Tu...

GlobeNewswire 2021-11-15 ERYTECH Provides Business and Financial Update for the Third Quarter of 2021

GlobeNewswire 2021-11-15 ERYTECH Announces Upcoming Poster Presentation at the 2021 American Society of Hematology Annual Mee...

GlobeNewswire 2021-11-10 ERYTECH Announces Publication of a Paper on Red-Blood Cell Characterization in High Impact Peer Revi...

GlobeNewswire 2021-11-09 ERYTECH to Present at the 12th Annual Jefferies Global London Healthcare Conference

NEXT BIOTECH/ QS0011095955

If you wish to receive reply to your feedback, please provide your email address.